Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Apr;81(4):589-604.
doi: 10.1111/bcp.12849. Epub 2016 Jan 26.

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis

Anick Bérard  1   2 , Noha Iessa  1   2 , Sonia Chaabane  1   2 , Flory T Muanda  1   2 , Takoua Boukhris  1   2 , Jin-Ping Zhao  1   2
Affiliations
Meta-Analysis

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis

Anick Bérard et al. Br J Clin Pharmacol. 2016 Apr.

Abstract

Aims: The aim of this study was to perform an up-to-date meta-analysis on the risk of cardiac malformations associated with gestational exposure to paroxetine, taking into account indication, study design and reference category.

Method: A systematic review of studies published between 1966 and November 2015 was conducted using embase and MEDLINE. Studies reporting major malformations with first trimester exposure to paroxetine were included. Potentially relevant articles were assessed and relevant data extracted to calculate risk estimates. Outcomes included any major malformations and major cardiac malformations. Pooled odds ratios and 95% confidence intervals were calculated using random-effects models.

Results: Twenty-three studies were included. Compared with non-exposure to paroxetine, first trimester use of paroxetine was associated with an increased risk of any major congenital malformations combined (pooled OR 1.23, 95% CI 1.10, 1.38; n = 15 studies), major cardiac malformations (pooled OR 1.28, 95% CI 1.11, 1.47; n = 18 studies), specifically bulbus cordis anomalies and anomalies of cardiac septal closure (pooled OR 1.42, 95% CI 1.07, 1.89; n = 8 studies), atrial septal defects (pooled OR 2.38, 95% CI 1.14, 4.97; n = 4 studies) and right ventricular outflow track defect (pooled OR 2.29, 95% CI 1.06, 4.93; n = 4 studies). Although the estimates varied depending on the comparator group, study design and malformation detection period, a trend towards increased risk was observed.

Conclusions: Paroxetine use during the first trimester of pregnancy is associated with an increased risk of any major congenital malformations and cardiac malformations. The increase in risk is not dependent on the study method or population.

Keywords: cardiac malformations; major malformations; meta-analysis; paroxetine; pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study selection in the systematic review and meta‐analysis of the effect of paroxetine use during pregnancy on the risk of major malformations and cardiac malformations. [Indexed from 1966 to November 10th, 2015].
Figure 2
Figure 2
Forest plots and pooled measures of risks for overall malformation and cardiac malformation according to the comparator group. (A) Major malformations, comparison: unexposed to paroxetine, (B) major malformations, comparison: unexposed to SSRIs, (C) major malformations, comparison: unexposed to any antidepressants, (D) cardiac malformations, Comparison: unexposed to paroxetine, (E) cardiac malformations, comparison: unexposed to SSRIs, (F) cardiac malformations, comparison: unexposed to any antidepressants.
See this image and copyright information in PMC

Comment in

References

    1. Marcus SM. Depression during pregnancy: rates, risks and consequences–motherisk update 2008. Can J Clin Pharmacol 2009; 16: e15–22. - PubMed
    1. Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry 2007; 19: 247–55. - PubMed
    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age‐of‐onset distributions of DSM‐IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593–602. - PubMed
    1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698–709. - PubMed
    1. Silva R, Jansen K, Souza L, Quevedo L, Barbosa L, Moraes I, Horta B, Pinheiro R. Sociodemographic risk factors of perinatal depression: a cohort study in the public health care system. Rev Bras Psiquiatr 2012; 34: 143–8. - PubMed

Publication types

MeSH terms